Bicarbonate or saline to prevent contrast-induced nephropathy?

>
By  |  October 23, 2008 | 

For patients with chronic renal insufficiency (gfr<60) undergoing coronary angiography, previous small RCTs showed bicarbonate to be superior to saline (abstract) (abstract) (abstract) in preventing CIN, but in a subsequent larger RCT, it was not found to be superior (when combined with N-acetylcysteine) (abstract). A recent meta-analysis found bicarbonate to be superior to saline, but noted signficant study heterogeneity and likely publication bias, calling for a larger RCT (meta-analysis). Now we have a larger RCT, in which 353 high risk patients (gfr <60 with DM, CHF, HTN, or age >75) were randomized to saline or bicarbonate infusions, and N-acetylcysteine was given at the discretion of the treating physician (in about half of patients). There was no difference in incidence of CIN between the groups (even when stratified by DM or receipt of N-acetylcysteine). In summary, it is unlikely that bicarbonate infusions are more beneficial than saline in preventing CIN (abstract)

Share This Post

One Comment

  1. Titilola Britto January 31, 2009 at 3:24 pm - Reply

    Standard saline protocols require 4 hours of infusion prior to test, while bicarbonate protocols only need one hour. In an ED, an urgent cardiac cath or an outpatient who does not want to spend nine+ hours at the facility. the bicarbonate protocol is effective and much more convenient.
    The other important point is that Clinicians assessment of and correction of volume depletion is still one of the most important preventive strategies in avoiding CIN (contrast induced nephropathy). acetylcysteine is probably voodoo and volume expabnsion in CKD patients at risk is still the most effective preventive strategy

Leave A Comment

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

About the Author: Danielle Scheurer

Danielle Scheurer, MD, MSCR, SFHM is a clinical hospitalist and the Chief Quality Officer at the Medical University of South Carolina in Charleston, South Carolina, where she also serves as Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She is also the President of SHM's Board of Directors and previously served as Physician Editor of The Hospitalist, SHM's monthly newsmagazine.

Categories

Related Posts

February 16, 2013 |  0
Synthetic marijuana, or “spice” has been linked to at least 16 cases of acute renal failure, according to the CDC. Unexplained renal failure in young otherwise healthy patients should prompt questioning about synthetic marijuana use (CDC site).
October 13, 2012 |  0
In this case-control study, patients on ACE/ARBs were significantly more likely than those not on ACE/ARBs to experience contrast-induced acute kidney injury (odds ratio 1.4, CI 1.1 to 1.8). However, this does not prove causality, and it is not clear that discontinuing ACE/ARBs before a contrast load would prevent the kidney injury (abstract).
August 20, 2012 |  0
In this large administrative database analysis of patients with non-valvular afib, patients with ESRD were significantly more likely to suffer stroke, system thromboembolism, and bleeding than those without ESRD; the risk of stroke/embolism was significantly lower for those on warfarin but not those on ASA, while the risk of bleeding was higher with both ASA […]
Go to Top